In particular, the increased concentrations of IP-10/CXCL10 in the TIME of pancreatic cancer have been linked to the recruitment of Tregs to the tumor site (19), which, in turn, may contribute to disease progression (67). This evidence concerns the gene CXCL10 and familial pancreatic carcinoma.